№ lp_1_11431
File format: docx
Character count: 4145
File size: 59 KB
This document provides a detailed outline of the questions included in the annual vaccination report for health care personnel in select Massachusetts facilities, focusing on influenza and COVID-19 vaccination data.
Year:
2026
Region / city:
Massachusetts
Topic:
Health Care Personnel Vaccination
Document Type:
Report
Agency / Organization:
Massachusetts Department of Public Health
Author:
Massachusetts Department of Public Health
Target Audience:
Health Care Personnel, Licensed Facilities in Massachusetts
Period of Validity:
Oct 1 2025 - Mar 31 2026
Approval Date:
N/A
Date of Last Update:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / city:
Wellington
Topic:
High Pathogenicity Avian Influenza (HPAI) H5N1 management in poultry
Document Type:
Submission template
Organization:
Ministry for Primary Industries (MPI)
Target Audience:
Poultry industry stakeholders, government partners, research entities
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2025
Region / city:
[insert local health board name]
Theme:
Vaccination
Document type:
Patient Group Direction (PGD)
Authorising organisation:
NHS Wales
Target audience:
Healthcare professionals (Registered)
Period of validity:
01 September 2025 - 31 March 2026
Approval date:
07 August 2025
Amendment date:
30 June 2025
Review date:
01 July 2026
Expiry date:
31 March 2026
Year:
2025
Region / city:
England
Topic:
Influenza immunisation
Document type:
Patient Group Direction (PGD)
Organisation:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Jamie Lopez-Bernal, Greta Hayward
Target audience:
Healthcare practitioners, NHS organisations
Period of validity:
From 1 September 2025 to 1 April 2026
Approval date:
3 July 2025
Revision history:
Updated annually, latest update 9 July 2025
Year:
2023
Region / City:
Australia
Theme:
Infectious Diseases Management, Healthcare
Document Type:
Guidelines
Organization:
Australian Government, Department of Health
Author:
Not specified
Target Audience:
Operators of residential care facilities
Action Period:
Ongoing
Approval Date:
16 May 2023
Amendment Date:
None
Context:
This document provides a comprehensive checklist for the management of acute respiratory infections, including COVID-19, influenza, and RSV, in residential care facilities.
Year:
2026
Region / City:
Beaufort County
Topic:
Influenza Vaccine Administration
Document Type:
Medical Consent Form
Organization / Institution:
Beaufort County Health Department
Author:
Beaufort County Health Department
Target Audience:
Patients receiving influenza vaccine
Period of Action:
Current vaccination season
Approval Date:
2026-02-06
Modification Date:
Not specified
Year:
2014-2015
Region / City:
United States
Topic:
Influenza Vaccination
Document Type:
Informational Guide
Organization / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
[xxx]
Target Audience:
Pharmacists, Healthcare Providers, Retailers
Period of Validity:
Current influenza season
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2025
Region / City:
Rice County, MN
Theme:
Influenza Vaccination
Document Type:
Consent Form
Organization:
Rice County Public Health
Author:
Rice County Public Health
Target Audience:
Residents of Rice County, individuals seeking influenza vaccination
Effective Period:
2025 / 2026 flu season
Approval Date:
Not specified
Modification Date:
Not specified
Contextual Description:
A consent form for receiving the influenza vaccine, including details on eligibility, payment information, and health history questions.
Year:
N/A
Region / City:
N/A
Theme:
Health Informatics
Document Type:
Educational Assignment
Author:
N/A
Target Audience:
Graduate Students, Public Health Rotation Participants
Period of Validity:
N/A
Date of Approval:
N/A
Date of Changes:
N/A
Year:
2025
Region / city:
Wales
Topic:
Inactivated influenza vaccine administration
Document type:
Addendum
Organization / institution:
NHS Wales
Author:
Welsh Medicines Advice Service (WMAS)
Target audience:
Registered healthcare professionals
Period of validity:
01 September 2025 - 31 March 2026
Approval date:
05 November 2025
Review date:
01 July 2026
Version:
1.0
Approval body:
Vaccine Clinical Advisory Group (VCAG)
Expiry date:
31 March 2026
Additional references:
Welsh Government. Health circulars. Available from https://www.gov.wales/health-circulars
Note:
[accessed 22 September 2025]
Context description:
Addendum to the NHS Wales Patient Group Direction (PGD) outlining the guidelines for administering inactivated influenza vaccines for the National Immunisation Programme 2025-2026.
Year:
2021
Region / City:
ARH
Topic:
Medical exemption from influenza vaccination
Document Type:
Request form
Organization / Institution:
ARH
Author:
ARH
Target Audience:
ARH employees
Period of Validity:
Until medical condition changes
Approval Date:
N/A
Modification Date:
N/A
Year:
2025
Region / city:
Northern Ireland
Subject:
Influenza vaccination
Document type:
Protocol
Organization / institution:
Public Health Agency (PHA)
Author:
Strategic Planning and Performance Group (SPPG)
Target audience:
Healthcare professionals
Period of validity:
1 September 2025 - 1 April 2026
Approval date:
03/09/25
Note:
Change history
Version 1.0:
New national protocol for inactivated influenza vaccine, 6 October 2021
Version 2.0:
Eligibility and vaccine details update for 2022-2023, 26 August 2022
Version 3.0:
Eligibility update for 2024-2025, 8 August 2024
Version 4.0:
Update with eligibility criteria for 2025-2026, 13 August 2025
Date of amendments:
Various
Expiration date:
1 April 2026
Year:
2025–2026
Country:
Wales
Healthcare system:
NHS Wales
Document type:
Patient Group Direction
Clinical area:
Immunisation
Vaccine:
Inactivated Influenza Vaccine
Service:
Primary Care Contractor Service: Immunisation (PCCS:I)
Setting:
Community Pharmacy
Operational period start:
01 September 2025
Review date:
01 July 2026
Expiry date:
31 March 2026
Version:
4.0
Legal framework:
Human Medicines Regulations 2012
Developing organisation:
Welsh Medicines Advice Service
Commissioning bodies:
Local Health Boards in Wales
Authoring body:
NHS Wales
Target professionals:
Registered pharmacy professionals
Professional registration:
General Pharmaceutical Council
Approval date (CPCAG):
10 July 2025
Ratification date (All Wales PGD Advisory Board):
16 July 2025
Governance responsibility:
Local Health Boards
Source type:
Official clinical governance document
Year:
2025
Region / City:
Victoria, Australia
Topic:
Acute Respiratory Infections, COVID-19, Influenza, Residential Care Facilities
Document Type:
Guidelines
Organization / Institution:
Department of Health, Victoria
Author:
Victorian Government
Target Audience:
Residential Care Facilities, Local Public Health Units, Healthcare Providers
Effective Period:
May 2025 - May 2028
Approval Date:
May 2025
Revision Date:
February 2024
Year:
2025
Region / city:
United Kingdom
Topic:
Immunization, Influenza Vaccine
Document Type:
Addendum
Organization / Institution:
UK Health Security Agency (UKHSA)
Author:
Suki Hunjunt, Alex Allen, Greta Hayward
Target Audience:
Health professionals, Immunization Programs
Effective Period:
1 September 2025 - 1 April 2026
Approval Date:
6 August 2025
Modification Date:
23 July 2025
Background:
Live attenuated influenza vaccine nasal spray suspension (Fluenz®) updated formula
Contextual Description:
Addendum to UKHSA PGD v15.0 detailing updates to the influenza vaccine composition and active strains.
Note:
Version number
Year:
2021
Country:
Global
Topic:
COVID-19 vaccination during pregnancy
Document Type:
Supplementary material
Study Type:
Systematic review
Authors:
Not specified
Target Audience:
Researchers, healthcare professionals, policy makers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Type of document:
Official information for health professionals
Topic:
Respiratory syncytial virus vaccination in pregnancy
Vaccine name:
Abrysvo®
Target population:
Pregnant women
Gestational age for administration:
28–36 weeks of pregnancy
Country:
Australia
Health program:
National Immunisation Program
Availability under NIP:
From 3 February 2025
Notifiable disease status:
RSV notifiable in Victoria since 22 February 2022
Regulatory authority:
Therapeutic Goods Administration
Monitoring scheme:
Black Triangle Scheme
Related legislation:
Public Health and Wellbeing Act 2008
Intended audience:
Health professionals
Storage requirements:
+2°C to +8°C
Business Rules for Quality and Outcomes Framework (QOF) 2023/2024/24-25 Vaccination and Immunisation
Note:
Author
Version Date:
01/04/2023–01/04/2024
Version:
48.049.0
Year:
2023
Region / City:
England
Subject:
Quality and Outcomes Framework, Vaccination, Immunisation
Document Type:
Guidelines
Organization:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES)
Target Audience:
GP Practices, GP System Suppliers, NHS England
Effective Period:
01/04/2023 – 31/03/2025
Approval Date:
01/04/2023
Amendment History Date:
01/04/2021, 01/04/2022, 01/04/2023
Supporting Documents:
Version 1.6 of the supporting information document
Reference Documents:
NHS Digital TRUD, Primary Care Domain Reference Set Portal
Note:
Year
Topic:
Immunisation Training
Document Type:
Competency Assessment
Target Audience:
Health care professionals in training
Year:
2023
Region / City:
Australia
Topic:
Japanese encephalitis vaccination
Document Type:
Consent form
Organization / Institution:
Australian Government
Author:
Unknown
Target Audience:
Individuals receiving JE vaccination
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified